However, in osteosarcoma, the IGF-1R/mTOR pathway has been implicated as a driver of anti-apoptotic signals and aberrant growth in many cancers making the pathway an attractive target for potential therapies [40, 41]. This evidence concerns the gene IGF1R and cancer.